World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
16563
World Ranking
3205
National Ranking
134

Denise L. Doolan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Denise L. Doolan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 242 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Denise L. Doolan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Denise L. Doolan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Denise L. Doolan is affiliated with the Australian Institute of Tropical Health and Medicine in Australia. Their body of work primarily spans the field of Medicine, with significant contributions to Infectious Diseases, Molecular Biology, Immunology, Oncology, and Epidemiology.

Their research topics include SARS-CoV-2 and COVID-19 Research, Viral-associated cancers and disorders, COVID-19 Clinical Research Studies, Immune Cell Function and Interaction, Lymphoma Diagnosis and Treatment, Malaria Research and Control, and SARS-CoV-2 detection and testing.

Several recent papers illustrate the scope and focus of their work:

  • The Rise of Non-Tuberculosis Mycobacterial Lung Disease, 2020, Frontiers in Immunology
  • Estimating the global burden of Epstein-Barr virus-related cancers, 2021, Journal of Cancer Research and Clinical Oncology
  • Suboptimal SARS-CoV-2−specific CD8 + T cell response associated with the prominent HLA-A*02:01 phenotype, 2020, Proceedings of the National Academy of Sciences
  • Systems serology detects functionally distinct coronavirus antibody features in children and elderly, 2021, Nature Communications
  • Integrated immune dynamics define correlates of COVID-19 severity and antibody responses, 2021, Cell Reports Medicine

Doolan frequently collaborates with a group of co-authors, including Carla Proietti, Thi H. O. Nguyen, Louise C. Rowntree, Katherine Kedzierska, and Daniel J. Browne. This network of collaborators has contributed to the depth and breadth of the research output.

Their publications are often found in venues such as bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Immunology, Clinical & Translational Immunology, International Journal for Parasitology, and SSRN Electronic Journal, reflecting an emphasis on immunology, infectious diseases, and translational research.

Best Publications

  • Acquired immunity to malaria.

    Denise L. Doolan;Carlota Dobaño;J. Kevin Baird

  • Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

    Ruobing Wang;Denise L. Doolan;Thong P. Le;Richard C. Hedstrom

  • Protection of Humans against Malaria by Immunization with Radiation-Attenuated Plasmodium falciparum Sporozoites

    Stephen L. Hoffman;Lucy M. L. Goh;Thomas C. Luke;Imogene Schneider

  • A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray.

    Peter D Crompton;Matthew A Kayala;Boubacar Traore;Kassoum Kayentao

  • The Rise of Non-Tuberculosis Mycobacterial Lung Disease

    Champa N. Ratnatunga;Viviana P. Lutzky;Andreas Kupz;Andreas Kupz;Denise L. Doolan;Denise L. Doolan

  • The Complexity of Protective Immunity Against Liver-Stage Malaria

    Denise L. Doolan;Stephen L. Hoffman

  • Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.

    Denise L. Doolan;Martha Sedegah;Richard C. Hedstrom;Peter Hobart

  • Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.

    Victor P. Argaet;Christopher W. Schmidt;Scott R. Burrows;Sharon L. Silins

  • Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers.

    Thong P. Le;Kevin M. Coonan;Richard C. Hedstrom;Yupin Charoenvit

  • Profiling humoral immune responses to P. falciparum infection with protein microarrays

    Denise L. Doolan;Denise L. Doolan;Denise L. Doolan;Yunxiang Mu;Berkay Unal;Suman Sundaresh

  • Immune effector mechanisms in malaria.

    Michael F Good;Denise L Doolan

  • Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine

    Ruobing Wang;Judith Epstein;Fe Maria Baraceros;Edward J. Gorak

  • Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.

    Denise L. Doolan;Scott Southwood;Daniel A. Freilich;John Sidney

  • Estimating the global burden of Epstein-Barr virus-related cancers.

    Yide Wong;Yide Wong;Michael T. Meehan;Scott R. Burrows;Scott R. Burrows;Denise L. Doolan;Denise L. Doolan

  • Degenerate Cytotoxic T Cell Epitopes from P. falciparum Restricted by Multiple HLA-A and HLA-B Supertype Alleles

    Denise L Doolan;Stephen L Hoffman;Scott Southwood;Peggy A Wentworth

  • IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.

    Denise L. Doolan;Stephen L. Hoffman

  • Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice

    Robert A. Gramzinski;Denise L. Doolan;Denise L. Doolan;Martha Sedegah;Martha Sedegah;Heather L. Davis

  • Suboptimal SARS-CoV-2-specific CD8 + T cell response associated with the prominent HLA-A*02:01 phenotype.

    Jennifer R. Habel;Thi H.O. Nguyen;Carolien E. van de Sandt;Carolien E. van de Sandt;Jennifer A. Juno

  • Sterile Protective Immunity to Malaria is Associated with a Panel of Novel P. falciparum Antigens

    Angela Trieu;Matthew A. Kayala;Chad Burk;Douglas M. Molina

  • HLA-DR-Promiscuous T Cell Epitopes from Plasmodium falciparum Pre-Erythrocytic-Stage Antigens Restricted by Multiple HLA Class II Alleles

    Denise L. Doolan;Scott Southwood;Robert Chesnut;Ettore Appella

  • Systems serology detects functionally distinct coronavirus antibody features in children and elderly.

    Kevin J. Selva;Carolien E. van de Sandt;Carolien E. van de Sandt;Melissa M. Lemke;Christina Y. Lee

  • DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation

    Denise L Doolan;Stephen L Hoffman

Frequent Co-Authors

Martha Sedegah
Martha Sedegah Naval Medical Research Center
Daniel J. Carucci
Daniel J. Carucci Naval Medical Research Center
Thomas L. Richie
Thomas L. Richie Naval Medical Research Center
Philip L. Felgner
Philip L. Felgner University of California, Irvine
Carlota Dobaño
Carlota Dobaño Barcelona Institute for Global Health
Michael F. Good
Michael F. Good Griffith University
James S. McCarthy
James S. McCarthy Walter and Eliza Hall Institute of Medical Research
Ivo Mueller
Ivo Mueller Walter and Eliza Hall Institute of Medical Research
Alex Loukas
Alex Loukas James Cook University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with various healthcare education pathways. For those looking to expand their clinical expertise, programs like the fnp to acute care np bridge program offer a strategic route to specialize in acute care settings, building on foundational nurse practitioner skills.

Accelerated options are available for driven individuals seeking to enter the healthcare field swiftly. The accelerated np programs provide an efficient way to earn a nurse practitioner degree online, allowing immunology enthusiasts to focus on advanced patient care related to immune system disorders.

For beginners without a nursing background, online pathways such as online adn programs for non nurses can be an excellent starting point. These programs equip students with essential nursing skills while maintaining flexibility through remote learning.

Moreover, those seeking a quicker transition to a nursing career might explore the easiest absn to get into. These accelerated Bachelor of Science in Nursing programs help students fast-track their education and begin working in immunology-related healthcare roles sooner.

Best Scientists Citing Denise L. Doolan

Trending Scientists

Recently Published Articles